Skeletal muscle apoptosis and autophagy are catabolic processes that contribute to muscle atrophy during aging, disease, and following muscle injury. In this article, we present data on skeletal muscle apoptosis, autophagy, and morphology in C57BL/6 mice following doxorubicin administration. More specifically, time-course data on caspase-3, caspase-8, caspase-9, calpain, and cathepsin activity are presented, along with data on ATG7, p62, LC3-I, and LC3-II protein expression. Data on skeletal muscle reactive oxygen species (ROS) production, muscle morphology, as well as body and muscle weights are also presented
Aim: Doxorubicin, a potent chemotherapeutic drug, has been demonstrated previously as an inducer of ...
The age-related loss of skeletal muscle mass and function (sarco-penia) is a consistent hallmark of ...
Background: Muscle wasting negatively impacts the progress of chronic diseases such as lung cancer (...
AbstractSkeletal muscle apoptosis and autophagy are catabolic processes that contribute to muscle at...
AbstractSkeletal muscle apoptosis and autophagy are catabolic processes that contribute to muscle at...
Autophagy is a catabolic process by which the cell targets and degrades cytoplasmic materials, such ...
AIM: Loss of skeletal muscle mass is a common clinical finding in cancer patients. The purpose of th...
Aim Loss of skeletal muscle mass is a common clinical finding in cancer patients. The purpose of thi...
Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle wasting in cancer ...
Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle wasting in cancer ...
Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle wasting in cancer ...
Apoptosis is a tightly regulated biological process that plays an important role in coordinating cel...
Muscle protein wasting in cancer cachexia is a critical problem. The underlying mechanisms are still...
Doxorubicin (Dox) has been one of the most effective chemotherapeutic drugs against a wide range of ...
International audienceThe conversion of skeletal muscle into meat, i.e. maturation, is a complex pro...
Aim: Doxorubicin, a potent chemotherapeutic drug, has been demonstrated previously as an inducer of ...
The age-related loss of skeletal muscle mass and function (sarco-penia) is a consistent hallmark of ...
Background: Muscle wasting negatively impacts the progress of chronic diseases such as lung cancer (...
AbstractSkeletal muscle apoptosis and autophagy are catabolic processes that contribute to muscle at...
AbstractSkeletal muscle apoptosis and autophagy are catabolic processes that contribute to muscle at...
Autophagy is a catabolic process by which the cell targets and degrades cytoplasmic materials, such ...
AIM: Loss of skeletal muscle mass is a common clinical finding in cancer patients. The purpose of th...
Aim Loss of skeletal muscle mass is a common clinical finding in cancer patients. The purpose of thi...
Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle wasting in cancer ...
Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle wasting in cancer ...
Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle wasting in cancer ...
Apoptosis is a tightly regulated biological process that plays an important role in coordinating cel...
Muscle protein wasting in cancer cachexia is a critical problem. The underlying mechanisms are still...
Doxorubicin (Dox) has been one of the most effective chemotherapeutic drugs against a wide range of ...
International audienceThe conversion of skeletal muscle into meat, i.e. maturation, is a complex pro...
Aim: Doxorubicin, a potent chemotherapeutic drug, has been demonstrated previously as an inducer of ...
The age-related loss of skeletal muscle mass and function (sarco-penia) is a consistent hallmark of ...
Background: Muscle wasting negatively impacts the progress of chronic diseases such as lung cancer (...